Cancer research
Research conducted by Washington University has made a significant breakthrough in the treatment of pancreatic cancer, a disease with a generally poor prognosis. By combining chemotherapy with a C-C chemokine receptor type 2 inhibitor, the study found that tumor-associated macrophages were targeted, leading to improved efficacy and restored T-cell immunity
Cancer research
Recent research has shed light on the increased risk of ischemic stroke in cancer patients who develop venous thromboembolism (VTE). A study published in Blood Advances observed that patients treated with direct oral anticoagulants (DOACs) had a higher cumulative incidence of ischemic stroke compared to those treated with low-molecular-weight heparin
Cancer
A recent study has shed light on the use of red blood cell (RBC) transfusions in patients with advanced cancer, particularly at the end of life. Researchers from King Faisal Specialist Hospital and Research Center conducted a retrospective cohort study involving 84 patients who received at least one RBC transfusion
Cancer research
Research published in Cancer Epidemiology, Biomarkers & Prevention has found that antiviral treatment for hepatitis C virus (HCV) significantly reduces the risk of developing lung cancer and non-Hodgkin lymphoma in patients with chronic HCV. The study, conducted by a team of researchers from Henry Ford Health System, followed a large
Cancer patients
Pulmonary embolism is a life-threatening disease that constitutes the second leading cause of death among cancer patients. Researchers from the University of Genova have discussed new findings in the management of pulmonary embolism in patients with cancer, highlighting the importance of anticoagulant therapy and the need for careful evaluation of
Cancer research
A groundbreaking study published in Supportive Care in Cancer has shed new light on the complex relationship between anxiety and self-efficacy in lung cancer patients. The research, conducted by a team of researchers from the Xiangya Nursing School of Central South University, collected data from 333 Chinese first-diagnosed lung cancer
Cancer research
Researchers from Ohio University have conducted a study to explore the impact of growth hormone (GH) signaling on therapy resistance and disease progression in bladder cancer. The study, published in the International Journal of Molecular Sciences, revealed that high tumoral expression of GH was associated with differential upregulation of genes
Cancer
A recent study published in BJC Reports has shed light on the critical factors that impact patient recruitment in phase I oncology trials. Researchers from the Institute of Cancer Research conducted a retrospective study involving 1671 patients, finding that polypharmacy and comorbidity have a significant association with trial recruitment, time
Cancer
A recent study by researchers from Duke University has shed light on the disparities in cancer outcomes among patients from low socioeconomic status neighborhoods in the United States. The study, which analyzed data from 266,269 hospital admissions, found that patients from neighborhoods with lower socioeconomic status had higher mortality
Cancer
Malnutrition is a major concern in cancer treatment, affecting one-third of patients, leading to treatment delays, poorer outcomes, and increased healthcare costs. At the ESPEN 2025 congress, Nutricia highlighted the importance of medical nutrition in addressing malnutrition, improving treatment outcomes, and enhancing quality of life. Despite established guidelines, nutritional screening
Cancer research
Researchers from the Islamic University of Science and Technology have made a significant contribution to the field of oncology with their innovative approach to diagnosing esophageal cancer. By leveraging deep learning analysis of digital pathological imagery data, the researchers have developed a framework that can predict metastatic potential and identify
Cancer
The third annual Future of Cancer Data Summit: Advancing Innovation, Enhancing Patient Care was held in Orlando, Florida, on September 12, 2025. The summit brought together experts in pathology, oncology, surgery, and data science to shape the future of cancer data and drive advances in research, care delivery, and patient
